Fusion of Lysostaphin to an Albumin Binding Domain Prolongs Its Half-Life and Bactericidal Activity in the Systemic Circulation
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fusion of Lysostaphin to an Albumin Binding Domain Prolongs Its Half-Life and Bactericidal Activity in the Systemic Circulation
Authors
Keywords
-
Journal
MOLECULES
Volume 24, Issue 16, Pages 2892
Publisher
MDPI AG
Online
2019-08-09
DOI
10.3390/molecules24162892
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Concept of an Ideal Antibiotic: Implications for Drug Design
- (2019) Márió Gajdács MOLECULES
- The Influence of Dimerization on the Pharmacokinetics and Activity of an Antibacterial Enzyme Lysostaphin
- (2019) Alexander V. Grishin et al. MOLECULES
- Synthetic biology of modular endolysins
- (2018) Hans Gerstmans et al. BIOTECHNOLOGY ADVANCES
- Phage-derived lysins as potential agents for eradicating biofilms and persisters
- (2018) Umender Sharma et al. DRUG DISCOVERY TODAY
- Improved Biodistribution and Extended Serum Half-Life of a Bacteriophage Endolysin by Albumin Binding Domain Fusion
- (2018) Johan Seijsing et al. Frontiers in Microbiology
- Half-life extension using serum albumin-binding DARPin® domains
- (2017) Daniel Steiner et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Staphylococcus simulans recombinant lysostaphin: Production, purification, and determination of antistaphylococcal activity
- (2016) I. S. Boksha et al. BIOCHEMISTRY-MOSCOW
- Cell wall hydrolases and antibiotics: exploiting synergy to create efficacious new antimicrobial treatments
- (2016) Michael Wittekind et al. CURRENT OPINION IN MICROBIOLOGY
- Recombinant Human Serum Albumin Fusion Proteins and Novel Applications in Drug Delivery and Therapy
- (2015) Brian Rogers et al. CURRENT PHARMACEUTICAL DESIGN
- What is the future of PEGylated therapies?
- (2015) Magdalena Swierczewska et al. EXPERT OPINION ON EMERGING DRUGS
- The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis
- (2015) Maarten Van Roy et al. ARTHRITIS RESEARCH & THERAPY
- Recombinant Lysostaphin Protects Mice from Methicillin-ResistantStaphylococcus aureusPneumonia
- (2014) Chen Chen et al. Biomed Research International
- Lysins: the arrival of pathogen-directed anti-infectives
- (2013) M. Pastagia et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Photonic Crystal Biosensor Based on Optical Surface Waves
- (2013) Valery Konopsky et al. SENSORS
- Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domain
- (2012) Mischa R. Müller et al. mAbs
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- Bactericidal synergy of lysostaphin in combination with antimicrobial peptides
- (2011) A. P. Desbois et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- PEGylating a bacteriophage endolysin inhibits its bactericidal activity
- (2011) Gregory Resch et al. AMB Express
- A Protease-Based Strategy for the Controlled Release of Therapeutic Peptides
- (2010) Hongjian Li et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice
- (2009) John F. Kokai-Kun et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Treatment of Methicillin-Resistant Staphylococcus aureus in Neonatal Mice: Lysostaphin Versus Vancomycin
- (2009) Frank X Placencia et al. PEDIATRIC RESEARCH
- Anti-serum albumin domain antibodies for extending the half-lives of short lived drugs
- (2008) L. J. Holt et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Engineering of a femtomolar affinity binding protein to human serum albumin
- (2008) A. Jonsson et al. PROTEIN ENGINEERING DESIGN & SELECTION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now